Stuart L. Goldberg

2.9k total citations
56 papers, 1.3k citations indexed

About

Stuart L. Goldberg is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Stuart L. Goldberg has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 18 papers in Genetics and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Stuart L. Goldberg's work include Acute Myeloid Leukemia Research (35 papers), Acute Lymphoblastic Leukemia research (16 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Stuart L. Goldberg is often cited by papers focused on Acute Myeloid Leukemia Research (35 papers), Acute Lymphoblastic Leukemia research (16 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Stuart L. Goldberg collaborates with scholars based in United States, France and Italy. Stuart L. Goldberg's co-authors include Er Chen, Marianne Laouri, Amy Guo, Gary J. Schiller, Nikita Mody‐Patel, Andrew L. Pecora, Mitra Corral, Hagop M. Kantarjian, Jörge E. Cortes and Arnaud Pigneux and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Stuart L. Goldberg

52 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stuart L. Goldberg United States	16	830	429	419	266	160	56	1.3k
Chirayu Auewarakul Thailand	18	343 0.4×	210 0.5×	237 0.6×	151 0.6×	146 0.9×	63	1.0k
Viviane Dubruille France	20	872 1.1×	605 1.4×	214 0.5×	405 1.5×	132 0.8×	68	1.4k
Sarah Marktel Italy	28	1.1k 1.3×	713 1.7×	572 1.4×	782 2.9×	182 1.1×	75	2.3k
Pierre Péterlin France	18	670 0.8×	123 0.3×	170 0.4×	347 1.3×	128 0.8×	108	1.0k
Yaël C. Cohen Israel	19	669 0.8×	162 0.4×	389 0.9×	537 2.0×	32 0.2×	141	1.4k
Noga Shem‐Tov Israel	23	1.0k 1.3×	205 0.5×	194 0.5×	584 2.2×	409 2.6×	85	1.7k
Ohad Benjamini Israel	15	247 0.3×	392 0.9×	178 0.4×	274 1.0×	72 0.5×	56	920
Kavita Raj United Kingdom	19	903 1.1×	270 0.6×	212 0.5×	255 1.0×	143 0.9×	62	1.2k
Fumitaka Nagamura Japan	16	543 0.7×	225 0.5×	238 0.6×	277 1.0×	122 0.8×	53	1.0k
Kevin Boyd United Kingdom	22	1.4k 1.6×	159 0.4×	1.3k 3.1×	773 2.9×	64 0.4×	83	2.0k

Countries citing papers authored by Stuart L. Goldberg

Since Specialization

Citations

This map shows the geographic impact of Stuart L. Goldberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart L. Goldberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart L. Goldberg more than expected).

Fields of papers citing papers by Stuart L. Goldberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart L. Goldberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart L. Goldberg. The network helps show where Stuart L. Goldberg may publish in the future.

Co-authorship network of co-authors of Stuart L. Goldberg

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart L. Goldberg. A scholar is included among the top collaborators of Stuart L. Goldberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart L. Goldberg. Stuart L. Goldberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miller, M. F., et al.. (2022). Financial Toxicity and Cost-Management Behaviors Among Patients with Myelodysplastic Syndromes. Blood. 140(Supplement 1). 8142–8143. 3 indexed citations

Hoffman, Kathleen, et al.. (2021). COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey. JMIR Public Health and Surveillance. 8(1). e29872–e29872. 98 indexed citations

Garcia‐Manero, Guillermo, António Almeida, Pierre Fenaux, et al.. (2018). Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial. Clinical Lymphoma Myeloma & Leukemia. 19(4). 213–219.e4. 3 indexed citations

Almeida, António, Pierre Fenaux, Guillermo Garcia‐Manero, et al.. (2018). Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial. Leukemia & lymphoma. 59(9). 2135–2143. 5 indexed citations

McCloskey, James, et al.. (2017). Outcomes with Augmented Hyper-CVAD (AHCVAD), a Pediatric Inspired HCVAD-Based Regimen, for Adults Younger Than 50 Years of Age with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL). Blood. 130. 5050–5050. 1 indexed citations

Goy, André, Eric Hansen, Srikesh Arunajadai, et al.. (2016). Impact of Charlson Comorbidity Index (CCI) and Refining the MIPI Index in Mantle Cell Lymphoma (MCL). Blood. 128(22). 2973–2973. 1 indexed citations

McCloskey, James, et al.. (2016). Features and Outcome of Patients (Pts) with New Diagnosis of Acute Myeloid Leukemia (AML) with Monocytic Differentiation (AML-Mo) Following Standard Induction Therapy. Do We Need a Different Strategy?. Blood. 128(22). 4017–4017.

Garcia‐Manero, Guillermo, Valeria Santini, António Almeida, et al.. (2016). Effect of Lenalidomide (LEN) Exposure on Response and Outcomes in Patients (Pts) with Lower-Risk Non-Del(5q) Myelodysplastic Syndromes (MDS). Blood. 128(22). 3190–3190. 1 indexed citations

Wang, Eunice S., Gary J. Schiller, Leonard T. Heffner, et al.. (2015). Plasma Vincristine Levels Are 100-Fold Higher with Marqibo® (Vincristine Sulfate LIPOSOME Injection) in Place of Standard Vincristine in Combination Chemotherapy of Patients ≥ 60 Years Old with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL). Blood. 126(23). 2491–2491. 3 indexed citations

10.

Goldberg, Stuart L., Pierre Fenaux, Michael Craig, et al.. (2014). An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes. Leukemia Research Reports. 3(2). 58–61. 66 indexed citations

11.

Garcia‐Manero, Guillermo, Selina M. Luger, Stuart L. Goldberg, et al.. (2013). A Randomized Phase II Study Of Sapacitabine In MDS Refractory To Hypomethylating Agents. Blood. 122(21). 2752–2752. 7 indexed citations

12.

Rowley, Scott D., Stuart L. Goldberg, Anthony R. Mato, et al.. (2012). Decitabine Plus Mini Fludarabine and Busulfan Yields Durable Engraftment with Low Relapse Rates in Elderly or Medically Infirm Patients with Myeloid Malignancies. Blood. 120(21). 1936–1936. 1 indexed citations

13.

Goldberg, Stuart L. & David P. Steensma. (2009). Myelodysplastic Syndrome Patients Obtaining a Cytogenetic Response to Outpatient Decitabine Experience Improved Hematological Responses and Longer Survival: Additional Analyses From the ADOPT Trial.. Blood. 114(22). 3817–3817. 3 indexed citations

14.

Iqbal, Afsheen N., et al.. (2008). Guillain-Barre Syndrome Complicating Multiple Myeloma. Blood. 112(11). 5135–5135. 2 indexed citations

15.

Goldberg, Stuart L.. (2007). Novel treatment options for transfusional iron overload in patients with myelodysplastic syndromes. Leukemia Research. 31. S16–S22. 13 indexed citations

16.

Goldberg, Stuart L., Jack W. Hsu, Scott D. Rowley, et al.. (2006). 5-Azacitidine Therapy in Elderly Patients with Acute Myelogenous Leukemia Yields Similar Survival Compared to 3+7 Induction Chemotherapy with Less Transfusional Support, Bacteremias, and Hospital Days.. Blood. 108(11). 4569–4569. 1 indexed citations

17.

Bisaccia, Emil, et al.. (2006). Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy. Journal of Clinical Apheresis. 21(3). 181–187. 33 indexed citations

18.

Rowley, Scott D., et al.. (2004). Unrelated donor hematopoietic stem cell transplantation for patients with hematologic malignancies using a nonmyeloablative conditioning regimen of fludarabine, low-dose total body irradiation, and rabbit antithymocyte globulin. Biology of Blood and Marrow Transplantation. 10(11). 784–793. 9 indexed citations

19.

Stiff, Patrick J., Stuart L. Goldberg, Richard J. Rosenbluth, et al.. (2000). Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplantation. 25(7). 797–799. 88 indexed citations

20.

Goldberg, Stuart L., et al.. (1992). Malignant head and neck germ cell tumours. The Journal of Laryngology & Otology. 106(3). 268–272. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact